New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Scilex Holding Company
SCLX
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

188M

Drug Manufacturers - General

Next Earning date - 12 Nov 2024

188M

Drug Manufacturers - General

Next Earning date - 12 Nov 2024

0.98USD
Shape0.12 ( 14.05%)
favorite-chart

Relative Strenght

3
favorite-chart

Volume Buzz

189%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

63%

Quote Panel

Shape
Updated October 28, 2024
1W 2.68 % 1M 7.77 % 3M -38.11 % 1Y -46.14 %

Key Metrics

Shape
  • Market Cap

    188.42M


  • Shares Outstanding

    191.79M


  • Share in Float

    116.21M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    0.9824


  • Average Volume

    1.20M


  • Beta

    1.165


  • Range

    0.732-2.63


  • Industry

    Drug Manufacturers - General


  • Website

    https://www.scilexholding.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

3.71x

P/S Ratio

-0.55x

P/B Ratio

-0.5

Debt/Equity

-233.9%

Net Margin

$-1.4

EPS

How SCLX compares to sector?

P/E Ratio

Relative Strength

Shape

SCLX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$90M

Shape449%

2025-Revenue

$0.40

Shape-29%

2025-EPS

$90M

Shape-514%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Alliance Global Partners

initialise

Previous: Not converted

2024-10-16

Now: Buy

Rodman & Renshaw

initialise

Previous: Not converted

2024-06-12

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+293%

0.16
vs -0.08

Q4.22

arrow
arrow

N/A

-0.16
vs 0.07

Q1.23

arrow
arrow

N/A

-0.22
vs -0.06

Q2.23

arrow
arrow

N/A

-0.16
vs -0.13

Q3.23

arrow
arrow

N/A

-0.63
vs 0.16

Q4.23

arrow
arrow

N/A

-0.25
vs -0.16

Q1.24

arrow
arrow

N/A

-0.26
vs -0.22

Q2.24

arrow
arrow

N/A

-0.18
vs -0.16

Q3.24

arrow
arrow

N/A

-0.14
vs -0.63

Q4.24

arrow
arrow

N/A

-0.13
vs -0.25

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+37%

11.4M  vs 8.3M

Q4.22

arrow
arrow

+44%

11.9M  vs 8.3M

Q1.23

arrow
arrow

+55%

10.6M  vs 6.8M

Q2.23

arrow
arrow

+59%

12.6M  vs 7.9M

Q3.23

arrow
arrow

-11%

10.1M  vs 11.4M

Q4.23

arrow
arrow

+13%

13.5M  vs 11.9M

Q1.24

arrow
arrow

+3%

10.9M  vs 10.6M

Q2.24

arrow
arrow

+30%

16.4M  vs 12.6M

Q3.24

arrow
arrow

+74%

17.6M  vs 10.1M

Q4.24

arrow
arrow

+53%

20.6M  vs 13.5M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-9%

-0.09
vs -0.20

Q4.22

arrow
arrow

-49%

-0.49
vs -0.09

Q1.23

arrow
arrow

-278%

-2.78
vs -0.49

Q2.23

arrow
arrow

-256%

-2.56
vs -2.78

Q3.23

arrow
arrow

+22%

0.22
vs -2.56

Q4.23

arrow
arrow

+12%

0.12
vs 0.22

Q1.24

arrow
arrow

+13%

0.13
vs 0.12

Q2.24

arrow
arrow

+18%

0.18
vs 0.13

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News